These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1317089)

  • 41. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum.
    Moench TR; Whaley KJ; Mandrell TD; Bishop BD; Witt CJ; Cone RA
    AIDS; 1993 Jun; 7(6):797-802. PubMed ID: 8395855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Real and false risks of local contraception: spermicides and the diaphragm].
    Zufferey MM
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(3):359-63. PubMed ID: 2993409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New developments in vaginal contraception.
    Popul Rep H; 1984; (7):H157-90. PubMed ID: 6321270
    [No Abstract]   [Full Text] [Related]  

  • 44. Vaginal delivery of new formulations of nonoxynol-9 coprecipitated with polyvinylpyrrolidone in rabbits. Comparisons between two formulation delivery systems.
    Zavos PM; Correa JR
    Contraception; 1997 Aug; 56(2):123-7. PubMed ID: 9315422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vaginal contraception using the Today and Benzaltex tampons].
    Jeker P; Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):411-6. PubMed ID: 3014676
    [No Abstract]   [Full Text] [Related]  

  • 46. Toxic shock syndrome and the vaginal contraceptive sponge.
    Faich G; Pearson K; Fleming D; Sobel S; Anello C
    JAMA; 1986 Jan; 255(2):216-8. PubMed ID: 3001376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques.
    Miller CJ; Alexander NJ; Gettie A; Hendrickx AG; Marx PA
    Fertil Steril; 1992 May; 57(5):1126-8. PubMed ID: 1315297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of three formulations of nonoxynol-9 containing vaginal spermicides. N-9 Formulation Preferences Study Group Committee.
    Coggins C; Elias C
    Int J Gynaecol Obstet; 2000 Mar; 68(3):267-8. PubMed ID: 10699202
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cytological study of the mode of contraceptive action of nonoxynol-9].
    Parier JL; Gonzales J
    Ann Pharm Fr; 1986; 44(4):277-83. PubMed ID: 3032062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transvaginal absorption and disposition of nonoxynol-9 in gravid rats.
    Buttar HS
    Toxicol Lett; 1982 Oct; 13(3-4):211-6. PubMed ID: 6293122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple, sensitive assay for the spermicide nonoxynol-9 in biological fluids by high-performance liquid chromatography.
    Beck GJ; Kossak D; Saxena SJ
    J Pharm Sci; 1990 Nov; 79(11):1029-31. PubMed ID: 1963449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of long-term use of nonoxynol-9 on vaginal flora.
    Schreiber CA; Meyn LA; Creinin MD; Barnhart KT; Hillier SL
    Obstet Gynecol; 2006 Jan; 107(1):136-43. PubMed ID: 16394051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
    Nelson AL
    Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxic-shock syndrome and the vaginal contraceptive sponge.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Feb; 33(4):43-4, 49. PubMed ID: 6318070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative spermicidal performance of iodinated and non-iodinated contraceptive formulations of nonoxynol-9 co-precipitated with polyvinylpyrrolidone.
    Zavos PM; Correa JR; Nosek D; Mohammadi F; Digenis GA
    Contraception; 1996 Jul; 54(1):39-41. PubMed ID: 8804807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(243):71769-85. PubMed ID: 18159651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spermicide permeation through biocompatible polymers.
    Saltzman WM; Tena LB
    Contraception; 1991 May; 43(5):497-505. PubMed ID: 1655352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and tolerability of the new contraceptive sponge Protectaid.
    Creatsas G; Elsheikh A; Colin P
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):91-5. PubMed ID: 12201327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
    Aznar R; Zamora G; Lozano M; Levi C
    Contraception; 1981 Sep; 24(3):235-44. PubMed ID: 7030612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
    Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.